HIV-1 vaccine-specific responses induced by Listeria vector vaccines are maintained in mice subsequently infected with a model helminth parasite, Schistosoma mansoni.

[1]  C. Bui,et al.  Successful vaccination of immune suppressed recipients using Listeria vector HIV-1 vaccines in helminth infected mice. , 2013, Vaccine.

[2]  Hasan Ahmed,et al.  Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials , 2012, The Journal of infectious diseases.

[3]  Guido Ferrari,et al.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial. , 2012, The New England journal of medicine.

[4]  J. Lieberman,et al.  Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIV , 2011, Journal of immune based therapies and vaccines.

[5]  Zhongxia Li,et al.  A live attenuated Listeria monocytogenes vaccine vector expressing SIV Gag is safe and immunogenic in macaques and can be administered repeatedly. , 2011, Vaccine.

[6]  A. Da'dara,et al.  Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10. , 2010, Vaccine.

[7]  S. Radulović,et al.  The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. , 2009, Vaccine.

[8]  J. Hampl,et al.  Impact of Preexisting Vector-Specific Immunity on Vaccine Potency: Characterization of Listeria monocytogenes-Specific Humoral and Cellular Immunity in Humans and Modeling Studies Using Recombinant Vaccines in Mice , 2009, Infection and Immunity.

[9]  P. Maciag,et al.  Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization. , 2009, Viral immunology.

[10]  M. Horwitz,et al.  Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis. , 2009, Vaccine.

[11]  D. Masopust.  Developing an HIV cytotoxic T‐lymphocyte vaccine: issues of CD8 T‐cell quantity, quality and location , 2009, Journal of internal medicine.

[12]  Zhongxia Li,et al.  Novel Vaccination Protocol with Two Live Mucosal Vectors Elicits Strong Cell-Mediated Immunity in the Vagina and Protects against Vaginal Virus Challenge1 , 2008, The Journal of Immunology.

[13]  S. Mehandru,et al.  Role of the gastrointestinal tract in establishing infection in primates and humans , 2008, Current opinion in HIV and AIDS.

[14]  J. Lieberman,et al.  Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys. , 2007, Vaccine.

[15]  Jeff F. Miller,et al.  Listeria as a vaccine vector. , 2007, Microbes and infection.

[16]  S. Way,et al.  Cutting Edge: Recombinant Listeria monocytogenes Expressing a Single Immune-Dominant Peptide Confers Protective Immunity to Herpes Simplex Virus-1 Infection1 , 2007, The Journal of Immunology.

[17]  M. Essex,et al.  Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice. , 2006, Vaccine.

[18]  R. Siliciano,et al.  DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. , 2005, Virology.

[19]  A. Pawłowski,et al.  Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. , 2005, Vaccine.

[20]  H. Bouwer,et al.  Listeria monocytogenes as a Vaccine Vector: Virulence Attenuation or Existing Antivector Immunity Does Not Diminish Therapeutic Efficacy1 , 2004, The Journal of Immunology.

[21]  P. Thomas,et al.  Immune biasing by helminth glycans , 2004, Cellular microbiology.

[22]  Dirk Engels,et al.  Soil-transmitted helminth infections: updating the global picture. , 2003, Trends in parasitology.

[23]  J. Fincham,et al.  Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic. , 2003, Acta tropica.

[24]  Jeff F. Miller,et al.  Safety and Shedding of an Attenuated Strain of Listeria monocytogenes with a Deletion of actA/plcB in Adult Volunteers: a Dose Escalation Study of Oral Inoculation , 2002, Infection and Immunity.

[25]  N. Glaichenhaus,et al.  Effect of intragastric and intraperitoneal immunisation with attenuated and wild-type LACK-expressing Listeria monocytogenes on control of murine Leishmania major infection. , 2002, Vaccine.

[26]  Y. Paterson,et al.  Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge. , 2001, Vaccine.

[27]  M. Tanner,et al.  Reinfection with Schistosoma haematobium following school‐based chemotherapy with praziquantel in four highly endemic villages in Côte d’Ivoire , 2001, Tropical medicine & international health : TM & IH.

[28]  F. Finkelman,et al.  The other side of the coin: the protective role of the TH2 cytokines. , 2001, The Journal of allergy and clinical immunology.

[29]  T. Hanke.  Vehicles for genetic vaccines against human immunodeficiency virus: induction of T cell-mediated immune responses. , 2001, Current molecular medicine.

[30]  G. Riveau,et al.  Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations. , 2000, The Journal of infectious diseases.

[31]  H. Gamble,et al.  Stat6 Signaling Promotes Protective Immunity Against Trichinella spiralis Through a Mast Cell- and T Cell-Dependent Mechanism1 , 2000, The Journal of Immunology.

[32]  J. Kazura,et al.  Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. , 1999, Journal of immunology.

[33]  N. Letvin.  Progress in the development of an HIV-1 vaccine. , 1998, Science.

[34]  R. Gregory,et al.  Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway , 1997, Gene Therapy.

[35]  A. Gown,et al.  Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Portnoy,et al.  Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines. , 1997, Vaccine.

[37]  F. Finkelman,et al.  Local TH1 and TH2 responses to parasitic infection in the intestine: regulation by IFN-gamma and IL-4. , 1996, Veterinary immunology and immunopathology.

[38]  A. García-Sastre,et al.  Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. , 1996, Cellular immunology.

[39]  P. Fallon,et al.  Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy , 1996, Parasitology.

[40]  E. Pearce,et al.  Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. , 1996, The Journal of infectious diseases.

[41]  R. Zinkernagel,et al.  Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination. , 1993, Vaccine.